BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 9986720)

  • 1. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
    J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
    Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
    Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chicoric acid analogues as HIV-1 integrase inhibitors.
    Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
    J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
    McDougall B; King PJ; Wu BW; Hostomsky Z; Reinecke MG; Robinson WE
    Antimicrob Agents Chemother; 1998 Jan; 42(1):140-6. PubMed ID: 9449274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicaffeoyltartaric acid analogues inhibit human immunodeficiency virus type 1 (HIV-1) integrase and HIV-1 replication at nontoxic concentrations.
    Reinke RA; King PJ; Victoria JG; McDougall BR; Ma G; Mao Y; Reinecke MG; Robinson WE
    J Med Chem; 2002 Aug; 45(17):3669-83. PubMed ID: 12166940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of novel hybrid dicaffeoyltartaric/diketo acid and tetrazole-substituted L-chicoric acid analogue inhibitors of human immunodeficiency virus type 1 integrase.
    Crosby DC; Lei X; Gibbs CG; McDougall BR; Robinson WE; Reinecke MG
    J Med Chem; 2010 Nov; 53(22):8161-75. PubMed ID: 20977258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
    Costi R; Di Santo R; Artico M; Roux A; Ragno R; Massa S; Tramontano E; La Colla M; Loddo R; Marongiu ME; Pani A; La Colla P
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1745-9. PubMed ID: 15026063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
    Lee SU; Shin CG; Lee CK; Lee YS
    Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase.
    Charvat TT; Lee DJ; Robinson WE; Chamberlin AR
    Bioorg Med Chem; 2006 Jul; 14(13):4552-67. PubMed ID: 16524737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
    Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
    J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
    Meadows DC; Mathews TB; North TW; Hadd MJ; Kuo CL; Neamati N; Gervay-Hague J
    J Med Chem; 2005 Jul; 48(14):4526-34. PubMed ID: 15999991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
    Mekouar K; Mouscadet JF; Desmaële D; Subra F; Leh H; Savouré D; Auclair C; d'Angelo J
    J Med Chem; 1998 Jul; 41(15):2846-57. PubMed ID: 9667973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
    Sriram D; Yogeeswari P; Senchani G; Banerjee D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2372-5. PubMed ID: 17376679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids.
    Zhu K; Cordeiro ML; Atienza J; Robinson WE; Chow SA
    J Virol; 1999 Apr; 73(4):3309-16. PubMed ID: 10074185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
    Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
    Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
    Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
    Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
    Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
    J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.